EGFR and lung carcinoma: As hypoxia could induce resistance to EGFR-TKIs in EGFR-mutant lung cancer [15, 16], we speculate cavity formation may impair the therapeutic response to EGFR-TKIs in EGFR-mutant ADC patients.